Haverford, PA, United States of America

James Levden

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Levden. Retrieved from https://idiyas.com/inventor/james-levden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by James Levden

Introduction

James Levden is an accomplished inventor based in Haverford, PA. He has made significant contributions to the field of dermatology, particularly in addressing the side effects of steroid use. His innovative approach has led to the development of a patent that aims to improve skin health.

Latest Patents

James Levden holds a patent titled "Reduction of cutaneous atrophy." This patent focuses on ameliorating the cutaneous atrophy associated with the topical use of steroids through the use of salts of certain alpha-hydroxy acids. This invention is crucial for patients who experience skin thinning as a side effect of steroid treatments.

Career Highlights

Levden is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, James has worked alongside notable colleagues such as Prakash Parah and Robert Lavker. These collaborations have enriched his research and have been instrumental in advancing his innovative projects.

Conclusion

James Levden's contributions to dermatology through his patent and work at Bristol-Myers Squibb Company highlight his commitment to improving patient care. His innovative solutions continue to pave the way for advancements in the treatment of skin conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…